LSLetícia Queiroz da Silva

Letícia Queiroz da Silva

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Letícia Queiroz da Silva has a total of 48 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Functional and Secretory Impairment of Endothelial Colony-Forming Cells in Patients with Acute Deep Vein Thrombosis

    by Leticia Silva, Stephany Huber, Silmara Montalvão, Sandra Silva, Erich de Paula, Amauri Silva-Junior, Arlindo Junior, Márcia de Abreu, Cássia Takano, Rebeca Brito, et al.

    Introduction - Deep Vein Thrombosis (DVT) is characterized by the formation of a thrombus within deep veins and results from different pathophysiological processes such as changes in the endothelium. Endothelial colony-forming cells (ECFCs) represent a valuable ex vivo model to study endothelial function, especially in disease states. This study characterized and evaluated the function of peripheral blood-derived ECFCs in acute DVT patients versus healthy individuals (HI). Methods: Circulating biomarkers were assessed via multiplex immunoassay and isolated ECFCs functionality was explored by an automated live-cell imaging system. Results: Early ECFC colonies were isolated from 13/25 (52%) DVT patients, presenting elevated IL-6, sCD40L, and PDGF-AB/BB, and reduced sICAM-1 and sVCAM-1 levels. Upon subsequent culture, only 4 of the 13 DVT clones successfully expanded (31%) compared to 14 of 18 HI clones (78%). Functionally, DVT-ECFCs displayed intrinsic impairments characterized by delayed wound repair kinetics and an accelerated rate of apoptosis during the first 24 hours. Furthermore, DVT-ECFCs exhibited an enhanced inflammatory profile in culture supernatant, characterized by higher levels of IL-6 (629.5 vs. 151.1 pg/mL, p=0.01), TNF (21.1 vs. 5.0 pg/mL, p=0.03), and sVCAM-1 (838.7 vs. 724.3 ng/mL, p=0.009). Conclusion: ECFCs from acute DVT patients seem to exhibit persistent cellular dysfunction and a hypersecretory inflammatory profile that likely contributes to defective vascular remodeling following a thrombotic event.

  • Open Access

    Platelet counts, but not neutrophil counts, are associated with non-bleeding-related mortality in patients with hematological malignancies and post-chemotherapy febrile neutropenia

    by Gabriela Romantini Salioni, Carla Roberta Peachazepi Moraes, Leticia Queiroz da Silva, Edwin Mayr, Bruno Kosa Lino Duarte, Erich V De Paula

  • Open Access

    Plasma Proteomic Profile of Chemotherapy‐Induced Severe Neutropenia: A Pilot Discovery Phase Study

    by Leticia Queiroz da Silva, Alexander Leonardo Silva‐Junior, Licia C. Silva‐Costa, Ivanio Teixeira Borba‐Junior, Bradley J. Smith, Edilson Tadeu Andrade, Bruno Kosa Lino Duarte, Marcos Paulo Colella, Thiago Martins Santos, Daniel Martins‐De‐Souza, et al.

    Transient severe neutropenia and thrombocytopenia are frequent during treatment of hematological malignancies and contribute to early mortality through sepsis and bleeding. While neutrophils and platelets are essential for host defense and tissue repair, little is known about immune adaptations during their depletion. In this pilot, discovery phase study, we evaluated the plasma proteome of 10 patients with chemotherapy‐induced severe neutropenia and thrombocytopenia, prior to any clinical complication. At sampling, mean neutrophil and platelet counts were 0.15 ± 0.18 × 10 9 /L and 34.6 ± 17.4 × 10 9 /L, respectively. A total of 762 proteins were identified, of which 71 were downregulated and 21 were upregulated in patients compared with healthy controls. Over‐representation analyses revealed that most downregulated proteins were related to immune responses, hemostasis, and protein metabolism. Notably, six upregulated proteins (USP8, IGFBP2, RCN1, B2M, LRG1, and C9) also mapped to these pathways, supporting the hypothesis that they may contribute to early systemic responses to chemotherapy‐induced myelotoxicity and tissue damage. This exploratory study leveraged a unique clinical window to examine how the human immune system responds to the marked reduction of neutrophils and platelets in the context of tissue and barrier disruption. The downregulation profile suggests impairment of the host's immunothrombotic defense, whereas the upregulated proteins may represent early compensatory mechanisms aimed at preserving homeostasis. Together, these findings provide insights into systemic responses during profound cytopenias and highlight candidate proteins that may mediate early adaptations to hematopoietic and tissue injury in patients undergoing intensive chemotherapy.

  • Open Access

    Accessing Altered Metabolic Profile in Acute Deep Vein Thrombosis Through Nuclear Magnetic Resonance Spectroscopy

    by Letícia Queiroz da Silva, Thyerre Santana da Costa, Lucas Gelain Martins, Silmara Aparecida de Lima Montalvão, Stephany Cares Huber, Sandra Martins Silva Soares, Ljubica Tasic, Joyce Maria Annichino-Bizzacchi

    Deep venous thrombosis (DVT) is characterized by the formation of a thrombus within deep veins. The unmet need to identify new biomarkers and causal risk factors in DVT patients has led to the use of novel techniques, such as metabolite analyses. This study aimed to characterize metabolic alterations in acute DVT patients using 1H-NMR spectroscopy and determine the persistence of these changes over a six-month follow-up. Metabolomics, particularly 1H-NMR spectroscopy, was performed on serum samples from acute DVT patients (first 30 days from diagnosis) and healthy controls (HC). Additionally, 10 plasma markers were evaluated using a Luminex kit. A total of 30 patients, with a mean age of 44 ± 12.5 years, primarily women (9 males:21 females), were included. Acute DVT patients showed elevated inflammatory markers, such as IL-6, IL-8, PDGF-AB/BB, and P-selectin, which later decreased in the follow-up group. However, adhesion molecules like sVCAM-1 and sICAM-1 have increased after six months. Metabolomics analysis revealed significantly decreased levels of glutamine, glucose, and branched-chain amino acids (BCAAs), alongside increased lactate levels in acute DVT samples. Metabolomic profiles showed only partial normalization at follow-up, indicating persistent metabolic dysregulation. Overall, the reduced glucose metabolism and increased lactate levels indicate anaerobic metabolism, likely caused by tissue hypoxia due to impaired blood flow. Glutamine, essential for DNA, ATP, and protein synthesis, was notably reduced, potentially impairing endothelial cell proliferation and vascular repair. The presence of adhesion molecules in the follow-up group confirms persistent endothelial dysfunction. These findings suggest that metabolic and endothelial alterations may persist long after acute inflammation resolves in DVT patients. In conclusion, the persistence of metabolic dysregulation suggests chronic metabolic stress in these patients, potentially resulting from ongoing endothelial damage, low-grade inflammation, or altered mitochondrial function due to past tissue hypoxia.


  • The Role of Platelet-Rich Plasma in the Mild and Severe Stages of Atherosclerotic Disease in Mice

    by Letícia Queiroz da Silva, Amauri da Silva Justo-Junior, Beatriz de Moraes Martinelli, Márcio Alves da Cruz, Stephany Cares Huber, Silmara Aparecida de Lima Montalvão, Luiz Henrique de Freitas Filho, Cristina Pontes Vicente, Joyce Maria Annichino-Bizzacchi

    Background: Platelet-rich plasma (PRP) has a high concentration of growth factors (GFs), which present a therapeutic wound healing effect. Despite having been correlated with an immunomodulatory fu... Plain language summary Platelet-rich plasma (PRP) contains growth factors, which stimulate normal wound healing. This product seems to be a good modulator of white blood cells and has not been inve...


  • The effect of lyophilized platelet rich-plasma on skin aging: a non-randomized, controlled, pilot trial

    by Letícia Queiroz da Silva, Rebeca Brito Bonani Cancela, Silmara Aparecida de Lima Montalvão, Stephany Cares Huber, Gislaine Vieira-Damiani, Renata Marchi Triglia, Joyce Maria Annichino-Bizzacchi

    Platelet-rich plasma (PRP) showed positive results in the improvement of skin aging. Lyophilized PRP can be interesting in clinical practice due to the fac


  • Open Access

    Increased inflammation and endothelial markers in patients with late severe post-thrombotic syndrome

    by Luis Fernando Bittar, Letícia Queiroz da Silva, Fernanda Loureiro de Andrade Orsi, Kiara Cristina Senger Zapponi, Bruna de Moraes Mazetto, Erich Vinícius de Paula, Silmara Aparecida de Lima Montalvão, Joyce Maria Annichino-Bizzacchi

    Post-thrombotic syndrome (PTS) is a limiting long-term complication present in 20–50% of patients with deep venous thrombosis (DVT) of the lower limbs. A panel of biomarkers with potential relevance to enhance knowledge on the pathophysiology of PTS was investigated. This case-control study included 93 patients with DVT in the lower limbs, 31 with severe PTS (cases) and 62 with mild/no PTS (controls), over 24 months after an acute episode. Thirty-one healthy individuals (HI) with no history of DVT were included as a reference to the population. FVIII activity, D-dimer, inflammatory cytokines, endothelial dysfunction markers, matrix metalloproteinases, and their inhibitors, tissue remodeling and growth factor levels were evaluated. The classification of PTS was, by the Villalta scale. Patients with severe PTS showed elevated levels of CRP, sICAM-1, sE-selectin, and decreased MMP-9 and MCP-1 levels when compared to patients with mild/no PTS. Moreover, DVT patients presented higher levels of FVIII and D-dimer when compared to HI. DVT patients present an inflammatory status, endothelial dysfunction and altered proteolysis MMPs activity, even a long time after the acute thrombotic episode, which is more significant in severe PTS. These results suggest a possible role of these mediators in the maintenance and worsening of PTS severity.


  • Platelet-Rich Plasma Lyophilization Enables Growth Factor Preservation and Functionality when Compared with Fresh Platelet-Rich Plasma

    by Letícia Queiroz da Silva, Silmara Aparecida de Lima Montalvão, Amauri da Silva Justo-Junior, José Luiz Rosenberis Cunha Júnior, Stephany Cares Huber, Carolina Caliári Oliveira, Joyce Maria Annichino-Bizzacchi

    Aims: To compare levels and activity of the growth factors between fresh and lyophilized platelet-rich plasma (PRP). Methods: Analysis of platelet concentration using fibroblast and human umbilical vein endothelial cell cultures were compared between fresh and lyophilized PRP obtained from peripheral blood. Results: After lyophilization, 54% of platelets were intact whereas the fresh showed no aggregation with agonists (levels under 20%). The concentration of growth factors (VEGF, EGF, TGF-β and PDGF) in both products were similar. Fresh and lyophilized PRPs induced proliferation in the fibroblasts at 24 h (0.303 vs 0.300, respectively). Conclusion: Lyophilized PRP appears to be an alternative to fresh PRP and the results evidenced the role of growth factors as a key element in the activity of this product.